Virtus LifeSci Biotech Clinical Trials ETF Rating $21.69 +0.50 (+2.36%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsShort InterestBuy This Stock Virtus LifeSci Biotech Clinical Trials ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBC Aggregate RatingModerate Buy 2.91Holdings in BBC have an aggregate rating of Moderate Buy based on 441 analyst ratings issued in the past year covering 49 companies (44.2% of the portfolio).BBC Aggregate Price Target$21.69High Prediction$21.69Average Prediction$21.69Low Prediction$21.69Holdings in BBC have an aggregate price target of $21.69 and a range of $21.69 to $21.69 covering 49 companies (44.2% of the portfolio).BBC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy30 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Clinical Trials ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 BBC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.54%VERVVerve Therapeutics$11.033.0221 of 5 stars2.33$14.57 32.1%91.05%PRTAProthena$6.43+0.5%3.6299 of 5 stars2.33$31.50 389.9%90.98%NUVBNuvation Bio$2.15-2.1%3.2158 of 5 stars3.20$7.17 232.7%50.97%NTLAIntellia Therapeutics$11.95+3.6%4.3436 of 5 stars2.65$33.37 179.2%200.95%CNTACentessa Pharmaceuticals$15.13+4.9%3.2439 of 5 stars3.00$27.89 84.3%10High Trading Volume0.93%ARQTArcutis Biotherapeutics$15.90+5.9%1.318 of 5 stars2.83$18.80 18.2%6Insider Trade0.93%ABCLAbCellera Biologics$4.24+5.7%2.1302 of 5 stars3.00$8.75 106.4%6Analyst ForecastHigh Trading Volume0.92%XERSXeris Biopharma$5.44+6.5%3.9686 of 5 stars2.83$6.25 14.9%60.92%TNGXTango Therapeutics$6.09+2.7%1.6779 of 5 stars3.00$12.20 100.3%6Positive News0.91%ORICOric Pharmaceuticals$10.85-2.3%4.5797 of 5 stars3.00$18.57 71.2%90.91%ETNB89BIO$11.12+1.1%2.1121 of 5 stars3.00$26.43 137.7%8News CoverageAnalyst Forecast0.90%AUTLAutolus Therapeutics$2.65+7.3%2.8669 of 5 stars3.00$9.32 251.7%5Positive News0.90%ELVNEnliven Therapeutics$23.00+2.4%2.8093 of 5 stars3.00$41.20 79.1%50.90%LENZLENZ Therapeutics$33.73-2.8%1.2474 of 5 stars3.17$46.60 38.2%6News CoverageAnalyst Revision0.90%SLNSilence Therapeutics$6.28-2.5%2.0613 of 5 stars2.71$33.83 438.7%7News CoverageAnalyst Downgrade0.90%SANASana Biotechnology$4.22+1.0%3.2715 of 5 stars3.00$9.17 117.2%70.90%OLMAOlema Pharmaceuticals$4.83+3.9%2.4372 of 5 stars3.00$24.50 407.2%4Positive News0.89%SMMTSummit Therapeutics$25.40+1.6%2.8679 of 5 stars2.79$34.67 36.5%14Gap Down0.89%SLNOSoleno Therapeutics$82.76+1.5%4.6038 of 5 stars3.09$108.70 31.3%11Analyst ForecastHigh Trading Volume0.89%PHVSPharvaris$23.80-5.3%1.5564 of 5 stars3.00$36.20 52.1%5Gap UpHigh Trading Volume0.89%MLTXMoonLake Immunotherapeutics$50.86+3.8%1.7171 of 5 stars3.00$74.50 46.5%7News Coverage0.89%ITOSiTeos Therapeutics$10.35+0.6%3.149 of 5 stars2.14$15.86 53.2%70.88%COGTCogent Biosciences$11.09+1.0%3.6008 of 5 stars2.82$18.00 62.3%11Insider TradeGap UpHigh Trading Volume0.88%CLDXCelldex Therapeutics$23.36+2.0%2.4992 of 5 stars2.89$50.11 114.5%9Positive News0.88%AKROAkero Therapeutics$52.73+2.2%3.5368 of 5 stars3.00$82.50 56.5%6Insider Trade0.88%ATXSAstria Therapeutics$6.62+3.9%1.6068 of 5 stars3.25$30.00 353.2%80.88%NRIXNurix Therapeutics$12.69+2.0%2.4669 of 5 stars2.83$29.47 132.2%18News CoverageEarnings ReportAnalyst ForecastAnalyst Revision0.88%KROSKeros Therapeutics$14.57+0.9%2.1043 of 5 stars2.50$30.56 109.7%140.87%SRRKScholar Rock$38.59+3.1%3.7367 of 5 stars3.14$42.67 10.6%70.87%GPCRStructure Therapeutics$19.57+2.9%2.6387 of 5 stars3.00$76.17 289.2%7Positive News0.87%ARCTArcturus Therapeutics$13.31-3.4%1.9961 of 5 stars3.11$54.00 305.7%90.87%BLTEBelite Bio$63.58+0.6%2.0232 of 5 stars3.00$96.67 52.0%4High Trading Volume0.86%CYTKCytokinetics$38.58+4.2%3.9785 of 5 stars2.93$70.92 83.8%15Positive News0.86%ALTAltimmune$4.26+2.9%2.2204 of 5 stars2.75$18.20 327.2%80.86%ARVNArvinas$7.87+1.0%3.9193 of 5 stars2.55$20.29 157.8%220.86%APGEApogee Therapeutics$38.88+1.9%3.1072 of 5 stars3.00$99.00 154.6%60.86%MREOMereo BioPharma Group$1.72+6.8%1.5784 of 5 stars3.20$7.20 318.6%5High Trading Volume0.86%KYMRKymera Therapeutics$44.90+0.9%3.1206 of 5 stars3.00$59.11 31.7%190.86%IRONDisc Medicine$57.74+1.5%3.2309 of 5 stars3.09$96.70 67.5%11Insider Trade0.86%RAPPRapport Therapeutics$14.63+0.2%1.6501 of 5 stars3.00$28.00 91.4%10.86%STOKStoke Therapeutics$12.06+1.7%4.1495 of 5 stars3.33$24.75 105.2%6News Coverage0.85%WVEWAVE Life Sciences$7.84+1.8%4.4499 of 5 stars2.92$20.50 161.5%120.85%VIRVir Biotechnology$5.50-2.7%3.609 of 5 stars2.88$30.25 450.0%8News CoverageAnalyst Upgrade0.85%RVMDRevolution Medicines$38.37+0.9%4.6255 of 5 stars3.00$68.00 77.2%110.85%NUVLNuvalent$84.59+4.5%3.3539 of 5 stars3.17$119.60 41.4%12Insider Trade0.85%IMVTImmunovant$18.59+2.5%1.4971 of 5 stars2.82$36.30 95.3%11News Coverage0.85%ANABAnaptysBio$26.95+2.9%1.6812 of 5 stars2.80$42.38 57.2%100.85%CGONCG Oncology$25.90-3.1%2.4357 of 5 stars3.08$56.80 119.3%12Positive NewsGap Down0.84%AVBPArriVent BioPharma$21.87+1.1%2.3045 of 5 stars3.14$39.29 79.6%7 This page (NYSEARCA:BBC) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn extra $1,000 per month?A little-known Title 15 provision could let you collect instant payouts — $100 to $1,000 — directly from your ...TradeSmith | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
